25 XP   0   0   10

OKYO Pharma Ltd ADR
Buy, Hold or Sell?

Let's analyse OKYO Pharma Ltd ADR together

PenkeI guess you are interested in OKYO Pharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of OKYO Pharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.

Quick analysis of OKYO Pharma Ltd ADR (30 sec.)










What can you expect buying and holding a share of OKYO Pharma Ltd ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.08
Expected worth in 1 year
$-0.41
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$-0.33
Return On Investment
-26.2%

For what price can you sell your share?

Current Price per Share
$1.25
Expected price per share
$1.2 - $1.58
How sure are you?
50%

1. Valuation of OKYO Pharma Ltd ADR (5 min.)




Live pricePrice per Share (EOD)

$1.25

Intrinsic Value Per Share

$-4.32 - $-1.43

Total Value Per Share

$-4.40 - $-1.51

2. Growth of OKYO Pharma Ltd ADR (5 min.)




Is OKYO Pharma Ltd ADR growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.5m$3.7m-$6.3m-243.5%

How much money is OKYO Pharma Ltd ADR making?

Current yearPrevious yearGrowGrow %
Making money-$16.7m-$6.8m-$9.9m-59.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of OKYO Pharma Ltd ADR (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#876 / 990

Most Revenue
#814 / 990

Most Profit
#693 / 990

Most Efficient
#169 / 990

What can you expect buying and holding a share of OKYO Pharma Ltd ADR? (5 min.)

Welcome investor! OKYO Pharma Ltd ADR's management wants to use your money to grow the business. In return you get a share of OKYO Pharma Ltd ADR.

What can you expect buying and holding a share of OKYO Pharma Ltd ADR?

First you should know what it really means to hold a share of OKYO Pharma Ltd ADR. And how you can make/lose money.

Speculation

The Price per Share of OKYO Pharma Ltd ADR is $1.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of OKYO Pharma Ltd ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in OKYO Pharma Ltd ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.08. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of OKYO Pharma Ltd ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.50-40.4%-0.50-40.4%-0.01-0.4%-0.11-8.4%-0.07-5.5%
Usd Book Value Change Per Share-0.08-6.6%-0.08-6.6%-0.01-0.5%-0.02-1.4%-0.03-2.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-6.6%-0.08-6.6%-0.01-0.5%-0.02-1.4%-0.03-2.2%
Usd Price Per Share1.68-1.68-0.00-0.34-0.17-
Price to Earnings Ratio-3.33--3.33-0.00--0.67--0.33-
Price-to-Total Gains Ratio-20.51--20.51--20.51--20.51-
Price to Book Ratio-21.51--21.51-0.00--4.30--2.15-
Price-to-Total Gains Ratio-20.51--20.51--20.51--20.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.25
Number of shares800
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.08-0.02
Usd Total Gains Per Share-0.08-0.02
Gains per Quarter (800 shares)-65.54-13.51
Gains per Year (800 shares)-262.16-54.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-262-2720-54-64
20-524-5340-108-118
30-786-7960-162-172
40-1049-10580-216-226
50-1311-13200-270-280
60-1573-15820-324-334
70-1835-18440-378-388
80-2097-21060-432-442
90-2359-23680-486-496
100-2622-26300-540-550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.014.00.012.5%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%4.012.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.015.06.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%5.011.00.031.3%

Fundamentals of OKYO Pharma Ltd ADR

About OKYO Pharma Ltd ADR

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Fundamental data was last updated by Penke on 2024-06-16 09:10:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of OKYO Pharma Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit OKYO Pharma Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • A Net Profit Margin of 0.0%¬†means that¬†$0.00 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.6%+168.6%
TTM--223.2%+223.2%
YOY--242.8%+242.8%
5Y--392.9%+392.9%
10Y--503.2%+503.2%
1.1.2. Return on Assets

Shows how efficient OKYO Pharma Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • -255.0% Return on Assets means that¬†OKYO Pharma Ltd ADR generated¬†$-2.55 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OKYO Pharma Ltd ADR:

  • The MRQ is -255.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -255.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-255.0%TTM-255.0%0.0%
TTM-255.0%YOY-126.3%-128.7%
TTM-255.0%5Y-266.4%+11.4%
5Y-266.4%10Y-279.7%+13.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-255.0%-11.6%-243.4%
TTM-255.0%-11.5%-243.5%
YOY-126.3%-10.9%-115.4%
5Y-266.4%-12.9%-253.5%
10Y-279.7%-14.2%-265.5%
1.1.3. Return on Equity

Shows how efficient OKYO Pharma Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • 0.0% Return on Equity means OKYO Pharma Ltd ADR generated $0.00¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-184.3%+184.3%
TTM-5Y-343.8%+343.8%
5Y-343.8%10Y-325.1%-18.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.8%+13.8%
TTM--14.6%+14.6%
YOY-184.3%-13.6%-170.7%
5Y-343.8%-18.1%-325.7%
10Y-325.1%-19.0%-306.1%

1.2. Operating Efficiency of OKYO Pharma Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient OKYO Pharma Ltd ADR is operating .

  • Measures how much profit OKYO Pharma Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • An Operating Margin of 0.0%¬†means the company generated $0.00 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--340.8%+340.8%
TTM--230.7%+230.7%
YOY--258.7%+258.7%
5Y--384.5%+384.5%
10Y--489.8%+489.8%
1.2.2. Operating Ratio

Measures how efficient OKYO Pharma Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.052-3.052
TTM-3.291-3.291
YOY-3.562-3.562
5Y-4.839-4.839
10Y-6.206-6.206

1.3. Liquidity of OKYO Pharma Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 0.72¬†means the company has $0.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.716. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.716. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.716TTM0.7160.000
TTM0.716YOY3.174-2.458
TTM0.7165Y2.112-1.396
5Y2.11210Y19.943-17.831
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7163.767-3.051
TTM0.7164.032-3.316
YOY3.1744.958-1.784
5Y2.1125.974-3.862
10Y19.9436.338+13.605
1.3.2. Quick Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • A Quick Ratio of 0.69¬†means the company can pay off $0.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.692. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.692. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.6920.000
TTM0.692YOY2.649-1.956
TTM0.6925Y1.988-1.296
5Y1.98810Y28.466-26.478
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6923.141-2.449
TTM0.6923.604-2.912
YOY2.6494.808-2.159
5Y1.9885.825-3.837
10Y28.4666.378+22.088

1.4. Solvency of OKYO Pharma Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of OKYO Pharma Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†OKYO Pharma Ltd ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.39¬†means that OKYO Pharma Ltd ADR assets are¬†financed with 139.5% credit (debt) and the remaining percentage (100% - 139.5%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 1.395. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.395. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.395TTM1.3950.000
TTM1.395YOY0.315+1.080
TTM1.3955Y0.751+0.644
5Y0.75110Y0.382+0.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3950.336+1.059
TTM1.3950.347+1.048
YOY0.3150.289+0.026
5Y0.7510.369+0.382
10Y0.3820.381+0.001
1.4.2. Debt to Equity Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.459-0.459
TTM-5Y0.415-0.415
5Y0.41510Y0.215+0.200
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.372-0.372
TTM-0.419-0.419
YOY0.4590.372+0.087
5Y0.4150.446-0.031
10Y0.2150.476-0.261

2. Market Valuation of OKYO Pharma Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings OKYO Pharma Ltd ADR generates.

  • Above 15 is considered overpriced but¬†always compare¬†OKYO Pharma Ltd ADR to the¬†Biotechnology industry mean.
  • A PE ratio of -3.33 means the investor is paying $-3.33¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -2.476. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.327. Based on the earnings, the company is expensive. -2
  • The TTM is -3.327. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.476MRQ-3.327+0.852
MRQ-3.327TTM-3.3270.000
TTM-3.327YOY--3.327
TTM-3.3275Y-0.665-2.662
5Y-0.66510Y-0.333-0.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.476-2.241-0.235
MRQ-3.327-2.903-0.424
TTM-3.327-2.857-0.470
YOY--3.454+3.454
5Y-0.665-6.141+5.476
10Y-0.333-6.401+6.068
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -4.266. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.734. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.734. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.266MRQ-5.734+1.468
MRQ-5.734TTM-5.7340.000
TTM-5.734YOY--5.734
TTM-5.7345Y-1.147-4.587
5Y-1.14710Y-0.573-0.573
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.266-2.850-1.416
MRQ-5.734-3.599-2.135
TTM-5.734-3.642-2.092
YOY--4.800+4.800
5Y-1.147-7.853+6.706
10Y-0.573-8.420+7.847
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of OKYO Pharma Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of -21.51 means the investor is paying $-21.51¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -16.002. Based on the equity, the company is expensive. -2
  • The MRQ is -21.506. Based on the equity, the company is expensive. -2
  • The TTM is -21.506. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.002MRQ-21.506+5.505
MRQ-21.506TTM-21.5060.000
TTM-21.506YOY--21.506
TTM-21.5065Y-4.301-17.205
5Y-4.30110Y-2.151-2.151
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.0021.852-17.854
MRQ-21.5062.209-23.715
TTM-21.5062.225-23.731
YOY-2.441-2.441
5Y-4.3013.709-8.010
10Y-2.1514.178-6.329
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OKYO Pharma Ltd ADR.

3.1. Institutions holding OKYO Pharma Ltd ADR

Institutions are holding 2.704% of the shares of OKYO Pharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Barclays PLC2.57520.00048558879755412.8643
2024-03-31Susquehanna International Group, LLP0.0611020310-14474-41.6111
2024-03-31HPM Partners LLC0.04010.00011331210008.1222
2024-03-31Geode Capital Management, LLC0.036401209000
2024-03-31HSBC Holdings PLC0.035901193300
2024-03-31Continuum Advisory, LLC0.0002050500
2024-03-31Renaissance Technologies Corp000-11800-100
2024-03-31Morgan Stanley - Brokerage Accounts000-13846-100
2023-12-31UBS Group AG000-95-100
Total 2.74890.0005913582+58389+6.4%

3.2. Funds holding OKYO Pharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Fidelity Nasdaq Composite Index0.03640.00011209000
Total 0.03640.00011209000.0%

3.3. Insider Transactions

Insiders are holding 25.72% of the shares of OKYO Pharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-15John P BrancaccioBUY166701.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of OKYO Pharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.082-0.0820%-0.006-92%-0.017-79%-0.028-66%
Book Value Per Share---0.078-0.0780%0.004-2152%-0.013-84%0.045-273%
Current Ratio--0.7160.7160%3.174-77%2.112-66%19.943-96%
Debt To Asset Ratio--1.3951.3950%0.315+343%0.751+86%0.382+265%
Debt To Equity Ratio----0%0.459-100%0.415-100%0.215-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.505-0.5050%-0.005-99%-0.106-79%-0.068-86%
Free Cash Flow Per Share---0.293-0.2930%-0.007-98%-0.062-79%-0.040-86%
Free Cash Flow To Equity Per Share--0.0620.0620%-0.004+107%0.013+370%0.003+2113%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.431--------
Intrinsic Value_10Y_min---4.322--------
Intrinsic Value_1Y_max---0.062--------
Intrinsic Value_1Y_min---0.187--------
Intrinsic Value_3Y_max---0.249--------
Intrinsic Value_3Y_min---0.778--------
Intrinsic Value_5Y_max---0.510--------
Intrinsic Value_5Y_min---1.602--------
Market Cap41545000.000-34%55836480.00055836480.0000%-+100%11167296.000+400%5583648.000+900%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-16.002+26%-21.506-21.5060%--100%-4.301-80%-2.151-90%
Pe Ratio-2.476+26%-3.327-3.3270%--100%-0.665-80%-0.333-90%
Price Per Share1.250-34%1.6801.6800%-+100%0.336+400%0.168+900%
Price To Free Cash Flow Ratio-4.266+26%-5.734-5.7340%--100%-1.147-80%-0.573-90%
Price To Total Gains Ratio-15.258+26%-20.507-20.5070%---20.5070%-20.5070%
Quick Ratio--0.6920.6920%2.649-74%1.988-65%28.466-98%
Return On Assets---2.550-2.5500%-1.263-50%-2.664+4%-2.797+10%
Return On Equity----0%-1.8430%-3.4380%-3.2510%
Total Gains Per Share---0.082-0.0820%-0.006-92%-0.017-79%-0.028-66%
Usd Book Value---2596318.187-2596318.1870%3726989.829-170%1620308.045-260%18800858.487-114%
Usd Book Value Change Per Share---0.082-0.0820%-0.006-92%-0.017-79%-0.028-66%
Usd Book Value Per Share---0.078-0.0780%0.004-2152%-0.013-84%0.045-273%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.505-0.5050%-0.005-99%-0.106-79%-0.068-86%
Usd Free Cash Flow---9738114.291-9738114.2910%-6916478.643-29%-4544954.038-53%-5048798.562-48%
Usd Free Cash Flow Per Share---0.293-0.2930%-0.007-98%-0.062-79%-0.040-86%
Usd Free Cash Flow To Equity Per Share--0.0620.0620%-0.004+107%0.013+370%0.003+2113%
Usd Market Cap41545000.000-34%55836480.00055836480.0000%-+100%11167296.000+400%5583648.000+900%
Usd Price Per Share1.250-34%1.6801.6800%-+100%0.336+400%0.168+900%
Usd Profit---16782045.683-16782045.6830%-6867556.403-59%-7207866.566-57%-10117462.002-40%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.082-0.0820%-0.006-92%-0.017-79%-0.028-66%
 EOD+2 -6MRQTTM+0 -0YOY+9 -185Y+10 -1710Y+10 -17

4.2. Fundamental Score

Let's check the fundamental score of OKYO Pharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.476
Price to Book Ratio (EOD)Between0-1-16.002
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.692
Current Ratio (MRQ)Greater than10.716
Debt to Asset Ratio (MRQ)Less than11.395
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.550
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.295
Ma 20Greater thanMa 501.354
Ma 50Greater thanMa 1001.419
Ma 100Greater thanMa 2001.438
OpenGreater thanClose1.230
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets5,204
Total Liabilities7,257
Total Stockholder Equity-2,053
 As reported
Total Liabilities 7,257
Total Stockholder Equity+ -2,053
Total Assets = 5,204

Assets

Total Assets5,204
Total Current Assets5,197
Long-term Assets7
Total Current Assets
Cash And Cash Equivalents 4,045
Net Receivables 980
Other Current Assets 171
Total Current Assets  (as reported)5,197
Total Current Assets  (calculated)5,197
+/-0
Long-term Assets
Property Plant Equipment 7
Long-term Assets  (as reported)7
Long-term Assets  (calculated)7
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,257
Long-term Liabilities0
Total Stockholder Equity-2,053
Total Current Liabilities
Short-term Debt 2,215
Short Long Term Debt 2,215
Accounts payable 2,388
Other Current Liabilities 2,654
Total Current Liabilities  (as reported)7,257
Total Current Liabilities  (calculated)9,472
+/- 2,215
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock131,386
Retained Earnings -125,698
Accumulated Other Comprehensive Income -11,453
Other Stockholders Equity 3,711
Total Stockholder Equity (as reported)-2,053
Total Stockholder Equity (calculated)-2,053
+/-0
Other
Capital Stock131,386
Cash and Short Term Investments 4,045
Common Stock Shares Outstanding 22,257
Liabilities and Stockholders Equity 5,204
Net Debt -1,830
Net Invested Capital 162
Net Working Capital -2,060
Property Plant and Equipment Gross 15
Short Long Term Debt Total 2,215



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
27,602
38,268
54,133
16,091
42,197
45,199
47,210
34,047
32,184
27,757
2,008
760
597
7,091
4,301
5,204
5,2044,3017,0915977602,00827,75732,18434,04747,21045,19942,19716,09154,13338,26827,602
   > Total Current Assets 
18,042
30,646
54,133
16,091
17,470
14,575
12,186
6,792
5,371
16,858
0
759
567
6,987
4,295
5,197
5,1974,2956,987567759016,8585,3716,79212,18614,57517,47016,09154,13330,64618,042
       Cash And Cash Equivalents 
17,970
5,384
26,640
16,072
17,034
14,339
11,824
6,465
5,129
3,925
2,008
628
235
6,889
2,701
4,045
4,0452,7016,8892356282,0083,9255,1296,46511,82414,33917,03416,07226,6405,38417,970
       Short-term Investments 
0
25,254
27,485
0
0
0
0
0
0
16,858
0
0
0
0
0
0
00000016,85800000027,48525,2540
       Net Receivables 
0
0
0
0
0
89
261
160
164
154
0
111
326
76
883
980
9808837632611101541641602618900000
       Other Current Assets 
36
6
5
12
272
66
60
61
55
19
0
20
6
21
713
171
1717132162001955616066272125636
   > Long-term Assets 
9,561
7,621
26,640
16,072
24,727
30,624
35,024
27,256
26,813
23,655
0
1
31
105
5
7
75105311023,65526,81327,25635,02430,62424,72716,07226,6407,6219,561
       Property Plant Equipment 
9,561
6,904
0
0
4,464
11,394
19,545
17,314
17,165
15,278
0
1
31
105
5
7
75105311015,27817,16517,31419,54511,3944,464006,9049,561
       Goodwill 
0
0
0
0
1,374
1,304
1,071
635
617
535
0
0
0
0
0
0
0000005356176351,0711,3041,3740000
       Intangible Assets 
0
718
0
0
18,889
17,926
14,408
9,306
9,032
7,841
0
0
0
0
0
0
0000007,8419,0329,30614,40817,92618,889007180
       Other Assets 
0
0
-26,640
-16,072
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-16,072-26,64000
> Total Liabilities 
145
86
80
79
833
183
248
151
181
259
91
427
737
1,772
1,353
7,257
7,2571,3531,77273742791259181151248183833798086145
   > Total Current Liabilities 
145
86
80
79
833
183
248
151
181
259
91
427
711
1,707
1,353
7,257
7,2571,3531,70771142791259181151248183833798086145
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
5
34
0
2,215
2,2150345000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,215
2,215000000000000000
       Accounts payable 
145
86
80
42
493
74
123
120
124
184
0
382
594
211
742
2,388
2,388742211594382018412412012374493428086145
       Other Current Liabilities 
0
0
0
37
340
110
125
31
57
75
91
45
112
1,462
611
2,654
2,6546111,462112459175573112511034037000
   > Long-term Liabilities 
73
60
53
26
308
48
74
81
86
147
0
293
27
65
565
0
0565652729301478681744830826536073
> Total Stockholder Equity
27,458
38,182
54,053
16,012
41,341
45,016
46,962
33,896
32,003
27,498
1,917
333
-140
5,319
2,947
-2,053
-2,0532,9475,319-1403331,91727,49832,00333,89646,96245,01641,34116,01254,05338,18227,458
   Common Stock
0
0
0
0
0
90,596
109,780
98,018
95,124
82,588
66,368
89,218
67,519
111,629
123,977
131,386
131,386123,977111,62967,51989,21866,36882,58895,12498,018109,78090,59600000
   Retained Earnings 
-2,975
12,187
28,964
-9,542
-29,647
-48,159
-66,005
-65,920
-64,712
-55,340
-64,451
-88,966
-85,878
-106,004
-112,426
-125,698
-125,698-112,426-106,004-85,878-88,966-64,451-55,340-64,712-65,920-66,005-48,159-29,647-9,54228,96412,187-2,975
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
30,432
25,995
25,089
25,554
70,988
2,578
112,809
1,798
1,866
86
0
-1
83,515
-13,124
2,408
3,711
3,7112,408-13,12483,515-10861,8661,798112,8092,57870,98825,55425,08925,99530,432



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4
Gross Profit-4-4
 
Operating Income (+$)
Gross Profit-4
Operating Expense-13,187
Operating Income-13,187-13,191
 
Operating Expense (+$)
Research Development6,338
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense13,1876,338
 
Net Interest Income (+$)
Interest Income0
Interest Expense-97
Other Finance Cost-0
Net Interest Income-97
 
Pretax Income (+$)
Operating Income-13,187
Net Interest Income-97
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-13,284-13,091
EBIT - interestExpense = -13,284
-13,284
-13,175
Interest Expense97
Earnings Before Interest and Taxes (EBIT)-13,187-13,187
Earnings Before Interest and Taxes (EBITDA)-13,183
 
After tax Income (+$)
Income Before Tax-13,284
Tax Provision--12
Net Income From Continuing Ops-13,272-13,272
Net Income-13,272
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,187
Total Other Income/Expenses Net-9797
 

Technical Analysis of OKYO Pharma Ltd ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of OKYO Pharma Ltd ADR. The general trend of OKYO Pharma Ltd ADR is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine OKYO Pharma Ltd ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OKYO Pharma Ltd ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.48 < 1.57 < 1.58.

The bearish price targets are: 1.2299 > 1.21 > 1.2.

Tweet this
OKYO Pharma Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OKYO Pharma Ltd ADR. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OKYO Pharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OKYO Pharma Ltd ADR. The current macd is -0.04806664.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the OKYO Pharma Ltd ADR price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for OKYO Pharma Ltd ADR. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the OKYO Pharma Ltd ADR price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
OKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartOKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OKYO Pharma Ltd ADR. The current adx is 25.42.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell OKYO Pharma Ltd ADR shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
OKYO Pharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OKYO Pharma Ltd ADR. The current sar is 1.475.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
OKYO Pharma Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OKYO Pharma Ltd ADR. The current rsi is 40.30. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
OKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) ChartOKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OKYO Pharma Ltd ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the OKYO Pharma Ltd ADR price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
OKYO Pharma Ltd ADR Daily Stochastic Oscillator ChartOKYO Pharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OKYO Pharma Ltd ADR. The current cci is -143.3046202.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
OKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) ChartOKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OKYO Pharma Ltd ADR. The current cmo is -24.64902707.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
OKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartOKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OKYO Pharma Ltd ADR. The current willr is -88.46153846.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
OKYO Pharma Ltd ADR Daily Williams %R ChartOKYO Pharma Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of OKYO Pharma Ltd ADR.

OKYO Pharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OKYO Pharma Ltd ADR. The current atr is 0.10650389.

OKYO Pharma Ltd ADR Daily Average True Range (ATR) ChartOKYO Pharma Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OKYO Pharma Ltd ADR. The current obv is 38,768,221.

OKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) ChartOKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OKYO Pharma Ltd ADR. The current mfi is 16.92.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
OKYO Pharma Ltd ADR Daily Money Flow Index (MFI) ChartOKYO Pharma Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OKYO Pharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

OKYO Pharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.295
Ma 20Greater thanMa 501.354
Ma 50Greater thanMa 1001.419
Ma 100Greater thanMa 2001.438
OpenGreater thanClose1.230
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of OKYO Pharma Ltd ADR with someone you think should read this too:
  • Are you bullish or bearish on OKYO Pharma Ltd ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about OKYO Pharma Ltd ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about OKYO Pharma Ltd ADR.

Receive notifications about OKYO Pharma Ltd ADR in your mailbox!